Background: Patients with acute coronary syndrome (ACS) frequently present with typical chest pain; however a considerable proportion may present with atypical symptoms. Objective: The purpose of this study was to evaluate the prognostic value of different presenting symptoms in ACS patients. Methods: Over a 5-month period in 2007, 6704 consecutive patients presenting with ACS were enrolled and categorized into three groups according to their presenting symptom (typical chest pain, atypical chest pain, and dyspnea). Data were collected from a prospective, multicenter, multinational, observational study from 6 countries. The baseline characteristics, therapy, and in-hospital outcomes were analyzed and compared in the three groups.
Introduction
Few studies have highlighted the clinical significance and outcome of acute coronary syndrome (ACS) in patients presenting with or without typical chest pain [1] [2] [3] [4] . Heberden was the first to describe typical ischemic chest pain while the concept of atypical chest pain remains more elusive with no standard definition. However, the generally used definition of atypical chest pain is any chest pain that does not meet Heberden's classic description [5, 6] . Breathlessness (dyspnea) alone can be the presenting symptom of ACS and was found to be present in 26% of patients. In another study, among 8.4% of the patients who presented without chest pain, nearly half of them had dyspnea only. Patients with dyspnea or with other painless presentations of ACS had worse outcomes [7, 8] . In comparison to ST-segment elevation myocardial infarction (STEMI), patients with non-ST-segment elevation ACS (NSTEACS) represent the majority of ACS patients (≈67%), however, data on the impact of atypical presenting symptoms in those patients are scarce [9] [10] [11] . Herein, we evaluate the prognostic value of the different presenting symptoms in patients with ACS (STEMI and NSTEACS). Patients' characteristics and hospital outcomes are described and compared among the three groups of patients presenting with typical and atypical chest pain and dyspnea.
Methods

Definition and data analysis
The data were collected from a 5-month prospective, multicenter study of the Gulf Registry of Acute Coronary Events (Gulf RACE) in 2007. The study recruited 6704 consecutive ACS patients from 6 Middle Eastern countries (Bahrain, Kuwait, Qatar, Oman, United Arab Emirates, and Yemen). The rationale and details of Gulf RACE have been described previously [12, 13] . Briefly, Gulf RACE aimed to identify the characteristics, clinical management, and hospital outcomes of ACS patients [STEMI and NSTEACS (NSTMI and unstable angina)]. Diagnosis of the different types of ACS and definitions of data variables were based on the American College of Cardiology clinical data standards [12] [13] [14] . Data on patient clinical characteristics, electrocardiographic findings, biochemical markers and therapy were collected by the attending physician in the accident and emergency department. At discharge, major adverse clinical events (re-ischemia, heart failure, cardiogenic shock, stroke, and mortality) were recorded.
Study groups
The definition of symptoms was prespecified in the registry and data were collected prospectively. For this analysis, regardless of the electrocardiographic changes, patients were divided into three groups depending on the nature of their predominant presenting symptom [9, 15, 16] . Group 1: The ''typical'' symptoms of myocardial ischemia include (1) precordial chest discomfort, pain, heaviness, or fullness, possibly radiating to the arm, shoulder, back, neck, jaw, epigastrium, or other location;(2) symptoms exacerbated by exertion or stress; (3) symptoms that may be relieved by rest or use of nitroglycerin; and (4) symptoms associated with shortness of breath, diaphoresis, weakness, nausea or vomiting, and light-headedness. Group 2: ''Atypical'' chest pain has been described as not severe; not prolonged; not classic in presentation; not exactly like prior cardiac symptoms; a burning, sharp, pleuritic, positional pain or discomfort that is reproducible on palpation of the chest wall and localizable by one finger; or pain or discomfort in areas of the upper body other than the chest, such as the arms, epigastrium, shoulder, and neck. Group 3: Dyspnea: the predominant complaint is sudden onset of unexplained shortness of breath. In the current analysis, we excluded patients who presented mainly with cardiac arrest, loss of consciousness, palpitation, generalized body aches, easy fatigue, or epigastric discomfort.
Statistical analysis
Differences in patient characteristics, management, and outcomes between the three groups were assessed using continuous variables summarized as median and interquartile ranges. Categorical variables are summarized as percentages, and compared using Chi square tests. In a subanalysis, atypical chest pain and dyspnea groups were gathered into one group (absent typical chest pain) and compared to the typical chest pain group.
Step-wise multivariate logistic regression was used to identify independent predictors of in-hospital mortality adjusted for baseline covariates (age, sex, diabetes mellitus, and blood pressure) among patients in the three groups. In addition, multivariate analysis was used to determine the predictors of the type of the presenting symptoms. A p-value of <0.05 was considered statistically significant. SPSS 14.0 (SPSS Inc., Chicago, IL, USA) statistical package was used for analysis. 
Results
Study population
The study enrolled 6704 consecutive patients presenting with ACS whereas the inclusion criteria were fulfilled in 6420 patients. On admission, 5349 patients (83%) had typical chest pain, 401(6%) had atypical chest pain, and 670 (11%) had dyspnea. Patients who had different presentations (284 patients) such as loss of consciousness (1.1%), palpitation (1.1%), others (2%) (i.e. generalized body aches, easy fatigability, or epigastric discomfort) were excluded from the current analysis. Table 1 summarizes the baseline biochemical and clinical profile in the three groups. Patients who presented with atypical pain or dyspnea were older compared to those with typical angina. They were more likely to be females and to have more cardiovascular risk factors. On admission, patients with dyspnea had significantly higher resting heart rate, systolic and diastolic blood pressure, and greater values of on-admission blood sugar and creatinine. Delay to seek medical care for more than 12 h was frequently seen in the dyspnea and atypical chest pain groups in comparison to the typical chest pain group (61% vs 51% vs 28%; p < 0.001). Fig. 1A demonstrates the breakdown of the presenting symptoms in STEMI and NSTEACS. Atypical presentation of ACS was high in patients with chronic obstructive pulmonary disease (COPD) when compared to patients without COPD (36% vs 19%; p < 0.001). 
Predictors of the presenting symptoms
In-hospital management
After hospital admission, there were differences in the medical and invasive management provided to patients based on their presenting symptoms. In-hospital coronary angiog- raphy was performed less frequently in patients with absent chest pain ( Table 2) . Patients with absent typical chest pain were also less likely to receive thrombolytic therapy and had delayed door to needle time (99 vs 55 min; p < 0.001). This group was also less likely to undergo percutaneous coronary intervention (3% vs 5%; p < 0.001) and to receive antiplatelet therapy, beta-blockers, heparin, and statins.
In-hospital outcomes
In comparison to patients presenting with typical angina, in-hospital outcomes were worse in those with absent chest pain in the form of significantly higher rates of heart failure, cardiogenic shock, stroke, and mortality ( Table 2) . After adjustment for confounders, absence of typical chest pain was associated with a higher mortality rate (odds ratio 2.0, 95% confidence intervals 1.29-2.75) ( Table 3 ). The mortality rate was even higher in patients presenting with dyspnea when compared to other groups (Fig. 1B) . Also, prolonged hospitalization was more evident in this group (5.5 ± 0.05 vs 6.0 ±0.13 days; p < 0.001). Fig. 3 highlights the impact of age, sex, diabetes mellitus, and renal failure on the mortality rate based on whether the patients presented with typical chest pain or not.
Discussion
The current study represents one of the largest observational studies comparing the impact of symptoms at the presentation of ACS on patient outcomes. Atypical presentation of ACS was reported in several studies ranging from 4.7% to 33% and was associated with worse outcomes [1, 4, 8, 9, 17, 18] . The current study supports these observations and reports for the first time the clinical predictors
Figure 3
In-hospital mortality according to symptom presentation stratified by age and sex (A) and the presence of co-morbidities i.e. diabetes or renal failure (B). of the absence of typical chest pain in ACS. Women were more likely to present with atypical symptoms in comparison to men and this gender gap had negative impact on the survival rate [13] .
The type and severity of symptoms that occur with ACS depend on the type and number of nociceptive afferent nerves activated and these afferent impulses may stimulate efferent impulses in the autonomic nervous system to produce symptoms [19] . The sex differences in ACS presentation may relate to different incidences of neuropathies. The incidence of neuropathies increases with advancing age, increasing body mass index, and a history of diabetes mellitus. In diabetes mellitus, autonomic neuropathy is common, and tends to affect the vagal nerves before it affects the sympathetic nerves [19] . Diabetic patients represented 50% of the atypical presentation group and this subset of population was associated with higher mortality rate particularly when dyspnea was the principal presentation [20] . Dyspnea alone can be the presenting symptom in 26-49% of patients with ACS [7] [8] [9] 20 ]. In the present study, the mortality rate increased 3 times in STEMI and NSTEACS when patients presented with dyspnea. Patients presenting with dyspnea were older, being female, more likely to have cardiovascular risk factors and higher heart rate and systolic blood pressure on presentation, lower left ventricular ejection fraction and greater in-hospital complications such as cardiogenic shock. According to Table 2 and Fig. 1B , we may conclude that dyspnea is the most important presenting symptom associated with worse hospital outcomes.
Furthermore, symptoms of ACS may be affected by the presence of certain traditional risk factors [14, [21] [22] [23] . Consistent with prior studies, our study demonstrated that patients presenting with dyspnea had greater morbidity and mortality as they were more likely to be older, females and diabetics. Patients with renal failure were more likely to present without typical angina and to be associated with higher mortality rate. Furthermore, the extent of infarcted myocardium may also influence the symptoms at presentation [15, 22] . This may be related to a lower frequency of chest pain among those with evolving NSTEMI (57% vs 77%) than among those with evolving STEMI (43% vs 23%) in the current study.
Our study demonstrated that atypical presentation of ACS is a significant independent predictor of in-hospital mortality after adjusting for measurable covariates. Previous studies that utilized different risk scores did not demonstrate the impact of the predominant presenting symptom on the short-term outcome in patients with ACS [24] . In the present study, the majority of patients with absent chest pain ranked high Global Registry of Acute Coronary Events risk scoring [24] . Our study highlighted that clinical presentation of ACS may have an additional prognostic impact.
The delay in seeking medical advice, improper medical assessment, inappropriate patients' disposition, and delay to give the evidence-based therapy in ACS was frequently encountered in patients who did not appreciate the typical symptoms of ACS. The mortality rate observed in AMI patients presenting without chest pain was attributed to the delay and underuse of optimal therapies [1] . The current study strongly advocates the role of the front-line physicians to consider the diagnosis of ACS even in the absence of typical symptoms, to set the appropriate management without delay, and not to deprive patients with STEMI from reperfusion therapy based on the absence of typical presentation [1] .
Limitations
Our data were collected from an observational study which is one of the limitations. However, well-designed observational studies provide valid results and do not systematically overestimate the results compared with the results of randomized controlled trials. As our data were demonstrated in a specific ethnic population, the results cannot be generalized; however, similar results were reported from different ethnicities [1, 4, 8, 9, 17, 18] .
Conclusion
Atypical presentation has a negative impact on the care and outcomes of patients with ACS, and therefore, it should not limit our decision making and management strategies particularly in high risk patients, i.e. diabetes mellitus, renal failure, old age, and COPD. Patients with ACS who present without typical angina are frequently undertreated. Clinical presentation may be an important added prognostic factor for patient risk stratification.
